Commonwealth of Pennsylvania Public School Empls Retrmt SYS Decreases Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS lowered its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,901 shares of the medical instruments supplier’s stock after selling 784 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in DENTSPLY SIRONA were worth $833,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Xponance Inc. raised its holdings in shares of DENTSPLY SIRONA by 7.3% in the fourth quarter. Xponance Inc. now owns 33,034 shares of the medical instruments supplier’s stock worth $627,000 after buying an additional 2,235 shares during the period. Counterpoint Mutual Funds LLC bought a new position in DENTSPLY SIRONA in the fourth quarter worth about $299,000. Signaturefd LLC grew its holdings in DENTSPLY SIRONA by 513.3% in the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier’s stock worth $84,000 after purchasing an additional 3,706 shares during the last quarter. Royce & Associates LP acquired a new position in DENTSPLY SIRONA during the 4th quarter valued at about $220,000. Finally, Envestnet Portfolio Solutions Inc. grew its stake in shares of DENTSPLY SIRONA by 82.9% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,901 shares of the medical instruments supplier’s stock worth $302,000 after acquiring an additional 7,206 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $15.60 on Thursday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 52 week low of $14.78 and a 52 week high of $33.42. The firm has a market capitalization of $3.10 billion, a PE ratio of -7.54, a P/E/G ratio of 1.80 and a beta of 0.98. The firm’s 50-day simple moving average is $17.81 and its 200 day simple moving average is $20.33.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.10%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is currently -14.07%.

Insiders Place Their Bets

In other news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction on Monday, March 3rd. The shares were bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.52% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities analysts recently commented on XRAY shares. Wells Fargo & Company decreased their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th. Mizuho reduced their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a report on Thursday, March 13th. Evercore ISI reaffirmed an “in-line” rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Robert W. Baird reduced their price objective on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research note on Friday, February 28th. Finally, Morgan Stanley lowered their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a report on Tuesday, December 17th. Twelve equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $23.33.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.